GlassScriptPhysician profile
Chuong H Pham
NPI 1467420992
$706.60
in general payments reported to CMS, 2019-2025
17 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180 · 2021: $17.46 · 2022: $220 · 2023: $98.87 · 2024: $80.85 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $288.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $115.72 | 2023-2024 | Veozah, Myrbetriq |
| Acessa Health INC. | $98.24 | 2019 | |
| Myovant Sciences INC. | $70.39 | 2022 | |
| Revance Therapeutics, INC. | $64.95 | 2025 | Daxxify |
| Hologic Sales and Service, LLC | $49.35 | 2021-2025 | Aptima |
| Organon LLC | $45.66 | 2022-2025 | Jada System |
| Aspira Women'S Health INC | $44.58 | 2019-2024 | Ova1 |
| Abbvie INC. | $40.39 | 2022 | |
| Sumitomo Pharma America, INC. | $26.39 | 2023 | Myfembree |
| Therapeuticsmd, INC. | $24.38 | 2019 | |
| Mylan Pharmaceuticals INC. | $23.69 | 2022 | |
| Mayne Pharma Commercial LLC | $20.76 | 2022 | |
| Evofem Biosciences, INC. | $20.76 | 2022 | |
| Coopersurgical, INC. | $19.02 | 2019 | |
| Renovia INC | $17.95 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $13.82 | 2023 | Citranatal |
| Meditrina | $10.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chuong Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.